Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling 432 shares, a decrease of 94.6% from the November 30th total of 7,995 shares. Based on an average trading volume of 71,435 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 71,435 shares, the short-interest ratio is presently 0.0 days.
Novozymes A/S Price Performance
Shares of OTCMKTS:NVZMY traded up $0.31 on Wednesday, hitting $64.25. The stock had a trading volume of 13,073 shares, compared to its average volume of 46,666. The firm’s 50 day moving average price is $62.42 and its 200-day moving average price is $65.14. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.00 and a current ratio of 1.61. Novozymes A/S has a twelve month low of $53.95 and a twelve month high of $75.99. The company has a market capitalization of $30.09 billion, a price-to-earnings ratio of 38.02, a price-to-earnings-growth ratio of 1.26 and a beta of 1.08.
Novozymes A/S Company Profile
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
Featured Articles
- Five stocks we like better than Novozymes A/S
- A month before the crash
- Wall Street Stockpicker Names #1 Stock of 2026
- “$6.6 Trillion Of Customer Bank Deposits At Risk”
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Once-in-a-generation financial shift is underway
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
